First Time Loading...

GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 10.9 USD -1.62%
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

WGS Price Targets Summary
GeneDx Holdings Corp

Wall Street analysts forecast WGS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WGS is 10.58 USD with a low forecast of 5.56 USD and a high forecast of 14.7 USD.

WGS Lowest Forecast
Wall Street Target
5.56 USD
49% Downside
WGS Average Forecast
Wall Street Target
10.58 USD
3% Downside
WGS Highest Forecast
Wall Street Target
14.7 USD
35% Upside
Lowest
Price Target
5.56 USD
49% Downside
Average
Price Target
10.58 USD
3% Downside
Highest
Price Target
14.7 USD
35% Upside
GeneDx Holdings Corp Competitors:
Price Targets
METROPOLIS
Metropolis Healthcare Ltd
6% Downside
FLGT
Fulgent Genetics Inc
30% Upside
PINC
Premier Inc
19% Upside
AGTI
Agiliti Inc
1% Upside
METROPOLIS
Metropolis Healthcare Ltd
6% Downside
FLGT
Fulgent Genetics Inc
30% Upside
PINC
Premier Inc
19% Upside
AGTI
Agiliti Inc
1% Upside
DGX
Quest Diagnostics Inc
2% Upside
DNTL
dentalcorp Holdings Ltd
54% Upside
FLRY3
Fleury SA
38% Upside
RDNT
RadNet Inc
12% Upside

Revenue
Forecast

Revenue Estimate
GeneDx Holdings Corp

For the last 4 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 1%. The projected CAGR for the next 3 years is 18%.

1%
Past Growth
18%
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
GeneDx Holdings Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

See Also

Summary
WGS intrinsic value, competitors valuation, and company profile.
DCF Valuation
WGS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WGS stock valuation using valuation multiples.
Wall Street Estimates
WGS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WGS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WGS's stock price target?
Price Target
10.58 USD

According to Wall Street analysts, the average 1-year price target for WGS is 10.58 USD with a low forecast of 5.56 USD and a high forecast of 14.7 USD.

What is GeneDx Holdings Corp's Revenue forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for GeneDx Holdings Corp's revenue is 1%. The projected CAGR for the next 3 years is 18%.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.